Clinical trials and tribulations at home push companies abroad

As securing approvals for clinical trials becomes time-consuming under the New Drug Advisory Committee (NDAC), pharmaceutical companies are increasingly considering shifting clinical trials abroad to expedite the process.

Read Full Story>>